Retatrutide

Retatrutide is an advanced research peptide currently being studied for its potential role in metabolic regulation and weight management. It is known as a triple-agonist peptide, meaning it interacts with three key metabolic hormone receptors: GLP‑1, GIP, and Glucagon receptors.

In research settings, Retatrutide is investigated for its potential effects on appetite control, energy balance, and metabolic efficiency.